Andy Merritt

1.3k citations

32 papers · 816 indexed · h-index 15

Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods 10
Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis 3
- Synthetic Organic Chemistry Methods 3
Molecular Biology
- Chemical Synthesis and Analysis 3
Physiology
Cellular and Molecular Neuroscience
Pharmacology
- Microbial Natural Products and Biosynthesis 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 3
Epidemiology
- Trypanosoma species research and implications 3
Public Health, Environmental and Occupational Health
- Malaria Research and Control 3

Co-authors: Duncan B. Judd John Brown Peter N. Lowe Guizhu Hong Liang Ye Andrew Lockhart Antony D. Gee Kristian Birchall
Cited by: Computational Theory and Mathematics Organic Chemistry Molecular Biology
Journals: Journal of Biological Chemistry (1 paper)The Journal of Organic Chemistry (1 paper)Frontiers in Immunology (1 paper)
Partner nations: United Kingdom United States Germany

In The Last Decade

Andy Merritt

30 papers receiving 798 citations

Peers

Countries citing papers authored by Andy Merritt

Since Specialization

Citations

This map shows the geographic impact of Andy Merritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Merritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Merritt more than expected).

Fields of papers citing papers by Andy Merritt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Merritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Merritt. The network helps show where Andy Merritt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andy Merritt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy Merritt Line = papers co-authored together Andy Merritt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Formation of mono- and dual-labelled antibody fragment conjugates via reversible site-selective disulfide modification and proximity induced lysine reactivity Chemical Science ·Ioanna A. Thanasi,Nathalie Bouloc,Clíona McMahon,Ning Wang,Péter A. Szijj,Tobias Butcher,Léa N. C. Rochet,Elizabeth A. Love,Andy Merritt,James R. Baker,Vijay Chudasama	2025	1
2	Optimising digital twin laboratories with conversational AIs: enhancing immersive training and simulation through virtual reality Digital Discovery ·Mae Taylor,Zaid Muwaffak,Matthew R. Penny,Blanka R. Szulc,Steven R. Brown,Andy Merritt,Stephen T. Hilton	2025	3
3	Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery Frontiers in Immunology ·Kayleigh Walker,Roberta Baravalle,Rachel Holyfield,Jacqueline Kalms,Helena Wright,C. Seewooruthun,Frederick W. Muskett,Anthony Scott-Tucker,Andy Merritt,Alistair J. Henry,Alastair D. G. Lawson,Gareth Hall,Christine E. Prosser,Mark D. Carr	2023	1
4	Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists European Journal of Medicinal Chemistry ·Monika Maciuszek,Almudena Ortega‐Gómez,Sanne L. Maas,José Garrido‐Mesa,Bartolo Ferraro,Mauro Perretti,Andy Merritt,Gerry A. F. Nicolaes,Oliver Soehnlein,Timothy M. Chapman	2021	4
5	Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation European Journal of Medicinal Chemistry ·Monika Maciuszek,Almudena Ortega‐Gómez,Sanne L. Maas,Mauro Perretti,Andy Merritt,Oliver Soehnlein,Timothy M. Chapman	2021	9
6	Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials Drug Discovery Today ·Peter Canning,Kristian Birchall,Catherine Kettleborough,Andy Merritt,P.J. Coombs	2020	7
7	Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty Bioorganic & Medicinal Chemistry Letters ·Jonathan M. Large,Kristian Birchall,Nathalie Bouloc,Andy Merritt,Ela Smiljanic-Hurley,Denise J. Tsagris,Mary C. Wheldon,Keith H. Ansell,P.J. Coombs,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	2019	11
8	Developing an Antibody–Drug Conjugate Approach to Selective Inhibition of an Extracellular Protein ChemBioChem ·Elizabeth A. Love,Afrah Sattikar,Hannah Cook,Kevin J. Gillen,Jonathan M. Large,Seema Patel,David J. Matthews,Andy Merritt	2018	15
9	Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG) Bioorganic & Medicinal Chemistry Letters ·Denise J. Tsagris,Kristian Birchall,Nathalie Bouloc,Jonathan M. Large,Andy Merritt,Ela Smiljanic-Hurley,Mary C. Wheldon,Keith H. Ansell,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	2018	20
10	Design of the LifeArc Index Set and Retrospective Review of Its Performance: A Collection for Sharing SLAS DISCOVERY ·Kristian Birchall,Andy Merritt,Afrah Sattikar,Catherine Kettleborough,Barbara Saxty	2018	5
11	Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines Bioorganic & Medicinal Chemistry Letters ·Jonathan M. Large,Kristian Birchall,Nathalie Bouloc,Andy Merritt,Ela Smiljanic-Hurley,Denise J. Tsagris,Mary C. Wheldon,Keith H. Ansell,P.J. Coombs,Catherine Kettleborough,David Whalley,Lindsay B. Stewart,Paul W. Bowyer,David A. Baker,Simon A. Osborne	2018	14
12	Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation PLoS Pathogens ·Alexander Zhyvoloup,Anat Melamed,Ian Anderson,Delphine Planas,Chen-Hsuin Lee,János Kriston-Vizi,Robin Ketteler,Andy Merritt,Jean‐Pierre Routy,Petronela Ancuța,Charles R. M. Bangham,Ariberto Fassati	2017	21
13	Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors SLAS DISCOVERY ·C. Southern,Jennifer M. Cook,Zaynab Neetoo‐Isseljee,Debra L. Taylor,Catherine Kettleborough,Andy Merritt,Daniel L. Bassoni,William J. Raab,Elizabeth R. Quinn,Tom S. Wehrman,Anthony P. Davenport,Andrew J. Brown,Andrew R. Green,Mark Wigglesworth,Steve Rees	2013	150
14	Fragment-based hit identification: thinking in 3D Drug Discovery Today ·Andrew Morley,Angelo Pugliese,Kristian Birchall,Justin Bower,Paul E. Brennan,Nathan Brown,Tim Chapman,Martin J. Drysdale,Ian H. Gilbert,Swen Hoelder,Allan M. Jordan,Steven V. Ley,Andy Merritt,David S. Miller,Martin E. Swarbrick,Paul G. Wyatt	2013	129
15	A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway Bioorganic & Medicinal Chemistry Letters ·Anne-Sophie Huart,Barbara Saxty,Andy Merritt,Marta Nekulová,Stephen J. Lewis,Yide Huang,Bořivoj Vojtěšek,Catherine Kettleborough,Ted R. Hupp	2013	12
16	Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils Journal of Biological Chemistry ·Andrew Lockhart,Liang Ye,Duncan B. Judd,Andy Merritt,Peter N. Lowe,Jennifer L. Morgenstern,Guizhu Hong,Antony D. Gee,John Brown	2004	184
17	Combinatorial Approaches to Asymmetric Catalysis. ChemInform ·Andy Merritt	2003	1
18	A practical synthesis of enantiopure (S)-4-(4-hydroxybenzyl)-oxazolidin-2-one Tetrahedron Asymmetry ·Rachel Green,Piers J. M. Taylor,Steven D. Bull,Tony D. James,Mary F. Mahon,Andy Merritt	2003	17
19	Combinatorial Library Design and Evaluation: Principles, Software Tools and Applications in Drug Discovery Drug Discovery Today ·Andy Merritt	2002	18
20	Application of High-throughput Screening Techniques to Drug Discovery Progress in medicinal chemistry ·Brian J. Cox,Andy Merritt,Alastair Binnie,M. Donnelly,Tom H. Mander,Jane Denyer,Brian Evans,Darren V. S. Green,Jane A. Lewis,Martin J. Valler,Steve P. Watson	2000	54

About Andy Merritt

Andy Merritt is a scholar working on Computational Theory and Mathematics, Virology and Pharmacology, having authored 32 papers that have together received 816 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (10 papers), Microbial Natural Products and Biosynthesis (4 papers), Asymmetric Synthesis and Catalysis (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Trypanosoma species research and implications (3 papers), Chemical Synthesis and Analysis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Malaria Research and Control (3 papers). The work is most often cited by research in Computational Theory and Mathematics (172 citations), Organic Chemistry (224 citations) and Molecular Biology (430 citations). Andy Merritt has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Duncan B. Judd, John Brown, Peter N. Lowe, Guizhu Hong, Liang Ye, Andrew Lockhart, Antony D. Gee, Kristian Birchall, Catherine Kettleborough and Elizabeth R. Quinn. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Organic Chemistry and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact